1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. CONTINEUM THERAPEUTICS INC. - ORDINARY SHARES - CLASS A
Contineum Therapeutics Inc. - Ordinary Shares - Class A
XNAS: CTNM

Contineum Therapeutics Inc (Class A) Live Stock Price Today, Share Analysis and Chart

about

Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds t...

Read More
14.62 -0.57 (-3.75%)
293.01% Gain from 52W Low
261.0K
XNAS Volume

XNAS 13 Jul, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
Not Eligible
Valuation Score
Expensive Valuation
10.0 / 100
Momentum Score
Technically Moderately Bullish
68.5 / 100
Analyst Price Target
29
1Yr Price target upside is 96%
3 analysts

15

S

6

W

5

O

0

T

SWOT Analysis

Contineum Therapeutics Inc (Class A) Live Price Chart

Switch to TradingView
Switch to

Contineum Therapeutics Inc (Class A) Live Price Chart

•••


Loading Fundamental data..


Loading data..
×